Newsfeeds - Spark Newswire

1 minute read

Earnings

Earnings Preview: Meridian Bioscience

Today, 6:45 AM

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Meridian Bioscience will likely report an Earnings Per Share (EPS) of $0.25.

VIVO

2 minute read

Cannabis Stock Gainers And Losers From February 1, 2022

By Benzinga Insights

Today, 6:45 AM

GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16

ACB

2 minute read

Cannabis Stock Gainers And Losers From January 31, 2022

By Benzinga Insights

Today, 6:45 AM

GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76

ACB

2 minute read

Meridian Bioscience Receives Additional NIH Award To Support Rapid Development Of Revogene Molecular Viral Respiratory Testing Panel; Total Amount ~$2.5M

By Benzinga Newsdesk

Today, 6:45 AM

Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has been awarded additional funding in the amount

VIVO

2 minute read

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News

By Shanthi Rexaline

Today, 6:45 AM

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

ABBV

1 minute read

Cannabis Stock Gainers And Losers From January 28, 2022

By Benzinga Insights

Today, 6:45 AM

GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33

ACB

2 minute read

News

Meridian Bioscience Launches Lyo-Ready qPCR Saliva-Specific Master Mixes For DNA & RNA Direct Detection

By Benzinga Newsdesk

Today, 6:45 AM

Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new master mixes that detect DNA and RNA in crude

VIVO

1 minute read

‘New FDA guidance on rapid tests w/Omicron…’ Mentions Abbott BinaxNOW antigen, Quidel QuickVue antigen, Meridian Bioscience Revogene single target test…Applied DNA Sciences Linea’ -Tweet From Nature Reporter

By Benzinga Newsdesk

Today, 6:45 AM

https://twitter.com/amymaxmen/status/1473736804352278538

ABT

1 minute read

FDA Website Shows Dec. 22-Dated update On Antigen Tests For Omicron: ‘The FDA continues to monitor and evaluate the impact of genetic variants on antigen tests…’

By Benzinga Newsdesk

Today, 6:45 AM

https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests?utm_medium=email&utm_source=govdelivery#omicronvariantimpact

ABT